{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "71610-849",
      "generic_name": "Sotalol Hydrochloride",
      "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC",
      "brand_name": "Sotalol Hydrochloride",
      "active_ingredients": [
        {
          "name": "SOTALOL HYDROCHLORIDE",
          "strength": "80 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "71610-849-80",
          "description": "180 TABLET in 1 BOTTLE (71610-849-80)",
          "marketing_start_date": "20240807",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aphena Pharma Solutions - Tennessee, LLC"
        ],
        "rxcui": [
          "1923426"
        ],
        "spl_set_id": [
          "1f2ee505-eb90-885d-e063-6394a90a46a1"
        ],
        "unii": [
          "HEC37C70XX"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "1f2ee516-a618-876f-e063-6394a90a3114",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20030201",
      "product_id": "71610-849_1f2ee516-a618-876f-e063-6394a90a3114",
      "application_number": "ANDA076140",
      "brand_name_base": "Sotalol Hydrochloride",
      "pharm_class": [
        "Adrenergic beta-Antagonists [MoA]",
        "Antiarrhythmic [EPC]",
        "Cardiac Rhythm Alteration [PE]"
      ]
    }
  ]
}